Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 203897

Expand all

PARICALCITOL (PARICALCITOL)
0.005MG/ML (0.005MG/ML)
Marketing Status: Prescription

Active Ingredient: PARICALCITOL
Proprietary Name: PARICALCITOL
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 0.005MG/ML (0.005MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A203897
Product Number: 002
Approval Date: Nov 2, 2017
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

PARICALCITOL (PARICALCITOL)
0.01MG/2ML (0.005MG/ML)
Marketing Status: Prescription

Active Ingredient: PARICALCITOL
Proprietary Name: PARICALCITOL
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 0.01MG/2ML (0.005MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A203897
Product Number: 003
Approval Date: Nov 2, 2017
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

PARICALCITOL (PARICALCITOL)
0.002MG/ML (0.002MG/ML)
Marketing Status: Discontinued

Active Ingredient: PARICALCITOL
Proprietary Name: PARICALCITOL
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 0.002MG/ML (0.002MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A203897
Product Number: 001
Approval Date: Nov 2, 2017
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:  Discontinued
Patent and Exclusivity Information